Impact of the COVID-19 pandemic on acute coronary syndromes
Autor: | Sophie Degrauwe, Elena Tessitore, Marco Roffi, Juan F. Iglesias, Lamyae Benzakour, François Mach, Murat Cimci, Stéphane Noble, Florian Rey, Nils Perrin |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Acute Coronary Syndrome/epidemiology/surgery Comorbidity Time-to-Treatment/statistics & numerical data Rate ratio Time-to-Treatment 03 medical and health sciences ddc:616.89 0302 clinical medicine Percutaneous Coronary Intervention Percutaneous Coronary Intervention/statistics & numerical data Medicine Humans 030212 general & internal medicine Myocardial infarction cardiovascular diseases Acute Coronary Syndrome Pandemics Aged COVID-19/epidemiology Retrospective Studies ddc:616 business.industry SARS-CoV-2 Incidence (epidemiology) Percutaneous coronary intervention COVID-19 Retrospective cohort study General Medicine Length of Stay Middle Aged medicine.disease Troponin/blood Confidence interval Troponin Out-of-Hospital Cardiac Arrest/epidemiology/therapy ST Elevation Myocardial Infarction/epidemiology/therapy Emergency medicine Conventional PCI ST Elevation Myocardial Infarction Female business 030217 neurology & neurosurgery Out-of-Hospital Cardiac Arrest |
Zdroj: | Swiss Medical Weekly, Vol. 150 (2020) P. w20448 |
ISSN: | 1424-7860 |
Popis: | AIM To assess the impact of the first wave of the COVID-19 pandemic on acute coronary syndromes and on the delay from symptom onset to first medical contact among patients presenting with ST-segment elevation myocardial infarction (STEMI), as well as to investigate whether there were patient-related reasons related to COVID-19 for delaying first medical contact. METHODS AND RESULTS All patients undergoing percutaneous coronary intervention (PCI) at the Geneva University Hospitals for acute coronary syndromes (ACS) during the first COVID-19 wave were compared with a control group consisting of all ACS patients who underwent PCI during the same period in 2019 and those treated in the period immediately preceding the pandemic. The primary outcome measure was the difference in the delay from symptom onset to first medical contact in the setting of STEMI between the COVID-19 period and the control period. Secondary outcome measures were the difference in ACS incidence and the impact of the COVID-19 pandemic on patients’ decisions to call the emergency services, assessed using a questionnaire. Delay from symptom onset to first medical contact was longer among patients suffering from STEMI in the COVID-19 period compared with the control period (112 min vs 60 min, p = 0.049). The incidence rate of ACS was lower during the COVID-19 period (incidence rate ratio 0.6, 95% confidence interval [CI] 0.449–0.905). ACS patients delayed their call to the emergency services mainly because of fear of contracting or spreading COVID-19 following hospital admission, as well as of adding burden to the healthcare system. CONCLUSION We observed prolonged delays from symptom onset to first medical contact and a decline in overall ACS incidence during the first wave of the COVID-19 pandemic, with a higher threshold to call for help among ACS patients. |
Databáze: | OpenAIRE |
Externí odkaz: |